Navigator Medicines
San Mateo, New Jersey, United States · Biotechnology, Health Care, Therapeutics
Navigator Medicines is a biotech company leading the advancement of biologics for targeted immune regulation & restoration. Founded in 2024 as a subsidiary of Sera Medicines, the Company is committed to developing new therapies for patients living with complex, heterogeneous autoimmune diseases. NAV-240, their clinical-stage bispecific antibody, targets OX40L and TNFα to address critical inflammat
Key facts
- Headquarters
- San Mateo, New Jersey, United States
- Employees
- 25
- Industries
- Biotechnology, Health Care, Therapeutics
- Status
- Private
- Website
- www.navigatormedicines.com
- Company page
Recent activity at Navigator Medicines
Navigator Medicines funding history
| Date | Round | Amount |
|---|---|---|
| Sep 2026 | Venture | $10.0M |
| Sep 2024 | Venture | $50.0M |
| Aug 2024 | Series A | $100.0M |
Leadership
- Andrew Levin, Board Member
- Wouter Joustra, Board Member
- Dana McClintock, Chief Medical Officer
Verified email and direct lines for Navigator Medicines’s decision-makers are on Fundz. See plans
Navigator Medicines in the news
- Phase 1b Trial Completed for Potential HS Therapy NAV-240 - Dermatology Times (Dec 03, 2025)
- Navigator Medicines Announces $100 Million Series A Financing and In-Licensing of NAV-240, a Potential Best-in-Class Anti-OX40L and Anti-TNFα Bispecific Antibody Therapeutic for Autoimmune Diseases - Business Wire (Aug 27, 2024)
- Phase 2a Evaluation of Dual OX40L/TNFα Antibody Begins in HS - Dermatology Times (Jan 09, 2026)
- Navigator Medicines Appoints Tausif ‘Tosh’ Butt as Chief Executive Officer and Khurem Farooq as Chairman of the Board of Directors - Business Wire (Feb 11, 2025)
Companies similar to Navigator Medicines
- Paradigm Biopharmaceuticals · Biotechnology, Health Care, Therapeutics
- Tenpoint Therapeutics · Biotechnology, Health Care, Therapeutics
- Gradalis · Biotechnology, Health Care, Therapeutics
- Anavo Therapeutics · Biotechnology, Health Care, Therapeutics
- Aethlon Medical · Biotechnology, Health Care, Therapeutics
About Navigator Medicines: questions and answers
What does Navigator Medicines do?
Navigator Medicines is a biotech company leading the advancement of biologics for targeted immune regulation & restoration. Founded in 2024 as a subsidiary of Sera Medicines, the Company is committed to developing new therapies for patients living with complex, heterogeneous autoimmune diseases. NAV-240, their clinical-stage bispecific antibody, targets OX40L and TNFα to address critical inflammat
Where is Navigator Medicines headquartered?
Navigator Medicines is headquartered in San Mateo, New Jersey, United States.
How many employees does Navigator Medicines have?
Navigator Medicines has about 25 employees.
Has Navigator Medicines raised funding?
Yes. Fundz has recorded 3 funding events for Navigator Medicines. The most recent, $10.0M, was in Sep 2026.
What is the latest news on Navigator Medicines?
On Sep 25, 2026, Navigator Medicines
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy